A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Autor: Nasser, Azmi, Liranso, Tesfaye, Adewole, Toyin, Fry, Nicholas, Hull, Joseph T., Chowdhry, Fatima, Busse, Gregory D., Cutler, Andrew J., Jones, Nandita Joshi, Findling, Robert L., Schwabe, Stefan
Zdroj: In Clinical Therapeutics August 2020 42(8):1452-1466
Databáze: ScienceDirect
Externí odkaz: